The US FDA has provided further clarification on Neurizon’s IND application for NUZ-001. ... Read More The post ‘One straightforward request’: Neurizon buoyant on FDA clarity appeared first on ...

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...

(NASDAQ: MDCX) (TSXV: MDCX) ("Medicus" or the "Company") is pleased to announce that its Investigational New Animal Drug (INAD File No.013880) has received Minor Use in Major Species Designation ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Innovative Dual-Target Drug May Lead to New Investigational Approach for Breast Cancer Patients Feb. 12, 2025 — Researchers discover new insights into how dual-target drug may supercharge cancer ...

Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases - WAYNE, Pa., ...

IT IS EVERYWHERE. PAUL SPERA, SPECIAL AGENT IN CHARGE AT THE DEA, HAS BEEN WATCHING THE DEADLY DRUG XYLAZINE TIGHTEN ITS GRIP ON NEW HAMPSHIRE, ESPECIALLY WHEN MIXED WITH OTHER DRUGS. IT IS ADDED ...

Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the drug closer to approval The field study for Laverdia-CA1’s (verdinexor ...

We believe that if people know more about the world’s creatures they will better care for them. That’s why we add new animals for you to discover – each and every day! Learn about any animal using the ...

Judge Declines to Block Musk From Accessing Agency Records or Ordering Firings Musk team’s next target is probationary Pentagon employees. Patel clears a procedural hurdle in the Senate, putting ...

ZoaDx, a newly launched clinical research organization, is dedicated to advancing animal health and agricultural sustainability through expert clinical research, tailored regulatory solutions, and ...